COBEHOLD
COBEHOLD and the 20 companies it controls according to the LEI register and the annual accounts: the structure, the figures, each company's health and where the risk sits.
Sum of the filed annual accounts of 18 of the 20 Belgian companies (fiscal years 2024-2025). Not a consolidation: receivables, participations and sales between group companies are not eliminated, so they count.
COBEHOLD also files consolidated accounts (fiscal year 2025): the real group figures, with intra-group positions eliminated. Checked does not read their figures yet; the document is at the National Bank's Central Balance Sheet Office.
Group risk
How healthy the group's Belgian companies are, and where the risk sits. A weak subsidiary can cost the parent money, and the other way round.
- The parent itself: COBEHOLD, healthy (71/100).
- 2 companies with negative equity: Verity (-€1.0m), Pegalum Holding (-€4,975).
- 7 companies with a loss in the latest year: Itineris Group (-€9.0m), IBEL (-€3.0m), Verity (-€1.9m), 2Themis3 (-€1.2m), Itineris Holding (-€680,247), CCI Athena 2024 (-€27,130) and 1 more.
- 60.2% of the added-up total assets sits in one company: COMPAGNIE BENELUX PARTICIPATIONS.
- 0.9% of the added-up total assets sits at companies with an elevated or high risk.
Group structure
Who consolidates whom according to the LEI register, completed with who holds more than half of the shares according to the annual accounts. Both mean control.
- COBEHOLD8 subsidiariesHealthy · 71€1.39bn €1.32bn 2025
- No verdictno figures
- No verdictno figures
- Elevated · 42€49.6m €13.6m 2024
- Fair · 58€41.2m €14.4m 2025
- Healthy · 68€11.7m €11.7m 2025
- Healthy · 69€29.3m €27.9m 2024
- COMPAGNIE BENELUX PARTICIPATIONS9 subsidiariesNo verdict€3.67bn €3.44bn 2025
- Healthy · 77€93.7m €93.4m 2025
- Healthy · 63€59.9m €59.9m 2025
- Healthy · 82€35.3m €35.3m 2025
- Healthy · 66€6.1m €6.1m 2024
- No verdict€33.4m €32.1m 2024
- Itineris Holding1 subsidiaryNo verdict€244.5m €233.7m 2025
- Itineris Group1 subsidiaryNo verdict€297.8m €235.3m 2025
- No verdict- -€4,975 2025
- Healthy · 68€27.1m €27.1m 2024
- MASCAGNA S.A.
- Fair · 47€47.2m €14.6m 2025
High risk Elevated Healthy Fair No verdict Amounts: total assets and equity from the latest accounts.
Events in the group
Bankruptcies, director changes, capital changes and other publications of all Belgian group companies, over the last two years.
-
Filip Vanderschueren resigns as director
-
1 director appointed, 1 director resigning
-
2 directors appointed
-
1 director appointed, 1 director resigning
-
Transaction in capital or shares
-
Transaction in capital or shares
-
Transaction in capital or shares
-
Charles de Liedekerke appointed as président de l'organe d'administration
-
Capital increase of €60,520
-
3 directors appointed
-
Capital contribution
-
3 directors appointed, 3 directors resigning
What is my exposure to this group?
The companies of this group you keep in your lists or follow, seen together.
Sign in to see which customers or suppliers from your lists belong to this group, and how they stand.
Where do these figures come from?
Completed with the annual accounts: a company of which another Belgian company holds more than half of the shares, by the list of holdings or the shareholder structure in its accounts, stands under that company, with the share. The register of ultimate beneficial owners (UBO) is not public.
The group's make-up comes from the LEI register (GLEIF): which company consolidates which other, directly or ultimately. A company whose link the register does not state is not listed here, even if it does belong to the group.
The amounts are those of the annual accounts each Belgian company filed with the National Bank, added up without consolidation. The verdict per company is that of its dossier on Checked.be. Everything is updated every night.
Updated on 29-09-2026